Qualigen Therapeutics, Inc. Announces $12 Million Registered Direct Offering
Share this article Share this article CARLSBAD, Calif., Dec. 16, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) ("Qualigen" or the "Company"), today announced it has entered into a definitive agreement with a single institutional investor for the purchase and sale for $12,000,000 of (i) 2,370,786 Common Shares, (ii) 1,000,000 Pre-Funded Warrants (iii) 1,348,314 Common Warrants exercisable immediately and (iv) 842,696 Common Warrants exercisable six (6) months after issuance...
New York United States Exchange Commission Sekisui Diagnostics A Gp Alliance Global Partners Qualigen Inc
Source: prnewswire.com